$9.98 7.5%
DNA Stock Price vs. AI Score
Data gathered: July 12

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Ginkgo Bioworks Holdings (DNA)

Analysis generated July 9, 2025. Powered by Chat GPT.

Ginkgo Bioworks Holdings operates as an artificial intelligence-driven, synthetic biology company. The company designs custom organisms for customers across multiple markets, including biosecurity, agriculture, and industrial biological engineering applications. Their mission revolves around making biology easier to engineer and leveraging genetic designs for practical applications.

Read full AI stock Analysis

Stock Alerts - Ginkgo Bioworks Holdings (DNA)

company logo Ginkgo Bioworks Holdings | July 11
Price is down by -7.7% in the last 24h.
company logo Ginkgo Bioworks Holdings | July 7
Price is down by -8.1% in the last 24h.
company logo Ginkgo Bioworks Holdings | July 2
Price is up by 7.8% in the last 24h.
company logo Ginkgo Bioworks Holdings | July 1
AI Score is down by 32.8% in the last couple of days.

Download our app to get future alerts delivered in real-time.

About Ginkgo Bioworks Holdings

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming.


Ginkgo Bioworks Holdings
Price $9.98
Target Price Sign up
Volume 1,510,000
Market Cap $616M
Year Range $5.57 - $16.36
Dividend Yield 0%
Analyst Rating 33% buy
Industry Biotechnology

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '2548M12M36M-91M-68M-1.680
Q4 '2444M9.6M34M-108M-143M-1.214
Q3 '2489M10M79M-56M-36M-1.080
Q2 '2456M31M25M-217M-137M-4.400
Q1 '2438M22M16M-166M-165M-0.080

Insider Transactions View All

Dmytruk Mark E. filed to sell 46,226 shares at $7.6.
May 22 '25
Coen Steven P. filed to sell 9,216 shares at $7.6.
May 22 '25
Coen Steven P. filed to sell 8,819 shares at $7.3.
April 23 '25
Dmytruk Mark E. filed to sell 45,453 shares at $7.3.
April 23 '25
Dmytruk Mark E. filed to sell 34,652 shares at $7.7.
March 6 '25

What is the Market Cap of Ginkgo Bioworks Holdings?

The Market Cap of Ginkgo Bioworks Holdings is $616M.

What is the current stock price of Ginkgo Bioworks Holdings?

Currently, the price of one share of Ginkgo Bioworks Holdings stock is $9.98.

How can I analyze the DNA stock price chart for investment decisions?

The DNA stock price chart above provides a comprehensive visual representation of Ginkgo Bioworks Holdings' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Ginkgo Bioworks Holdings shares. Our platform offers an up-to-date DNA stock price chart, along with technical data analysis and alternative data insights.

Does DNA offer dividends to its shareholders?

As of our latest update, Ginkgo Bioworks Holdings (DNA) does not offer dividends to its shareholders. Investors interested in Ginkgo Bioworks Holdings should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Ginkgo Bioworks Holdings?

Some of the similar stocks of Ginkgo Bioworks Holdings are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.

Chat with AltIndex AI

👋 Welcome to AltIndex AI Chat!

Ask about:
  • Top Stocks
  • AI score insights
  • Trending investment opportunities
  • How to use AltIndex
You need to log in to use AltIndex AI Chat.
Disclaimer: AI outputs may be incorrect. This is for informational purposes only and not a substitute for professional financial advice.